Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29


Rapid kidney function decline and mortality risk in older adults.

Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, Newman AB, Sarnak MJ.

Arch Intern Med. 2008 Nov 10;168(20):2212-8. doi: 10.1001/archinte.168.20.2212.


Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan.

Cheng TY, Wen SF, Astor BC, Tao XG, Samet JM, Wen CP.

Am J Kidney Dis. 2008 Dec;52(6):1051-60. doi: 10.1053/j.ajkd.2008.05.030. Epub 2008 Aug 15.


Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population.

Astor BC, Hallan SI, Miller ER 3rd, Yeung E, Coresh J.

Am J Epidemiol. 2008 May 15;167(10):1226-34. doi: 10.1093/aje/kwn033. Epub 2008 Apr 2.


Prevalence of chronic kidney disease in the United States.

Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS.

JAMA. 2007 Nov 7;298(17):2038-47.


Chronic kidney disease: effects on the cardiovascular system.

Schiffrin EL, Lipman ML, Mann JF.

Circulation. 2007 Jul 3;116(1):85-97. Review.


Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study.

Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, Chambless LE, Coresh J.

J Am Soc Nephrol. 2007 Apr;18(4):1307-15. Epub 2007 Mar 7.


When is baseline adjustment useful in analyses of change? An example with education and cognitive change.

Glymour MM, Weuve J, Berkman LF, Kawachi I, Robins JM.

Am J Epidemiol. 2005 Aug 1;162(3):267-78. Epub 2005 Jun 29.


Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study.

Perkins BA, Nelson RG, Ostrander BE, Blouch KL, Krolewski AS, Myers BD, Warram JH.

J Am Soc Nephrol. 2005 May;16(5):1404-12. Epub 2005 Mar 23.


Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease.

Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG.

Ann Intern Med. 2004 Dec 21;141(12):929-37.


Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY.

N Engl J Med. 2004 Sep 23;351(13):1296-305. Erratum in: N Engl J Med. 2008;18(4):4.


Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.

de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM.

Circulation. 2004 Aug 24;110(8):921-7. Epub 2004 Aug 9.


Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ.

J Am Soc Nephrol. 2004 May;15(5):1307-15.


Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Circulation. 2003 Oct 28;108(17):2154-69. Review. No abstract available.


Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK).

Eknoyan G, Hostetter T, Bakris GL, Hebert L, Levey AS, Parving HH, Steffes MW, Toto R.

Am J Kidney Dis. 2003 Oct;42(4):617-22. Review. No abstract available.


The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.

Jafar TH, Schmid CH, Stark PC, Toto R, Remuzzi G, Ruggenenti P, Marcantoni C, Becker G, Shahinfar S, De Jong PE, De Zeeuw D, Kamper AL, Strangaard S, Levey AS.

Nephrol Dial Transplant. 2003 Oct;18(10):2047-53.


Absolute level and rate of change of albuminuria over 1 year independently predict mortality and cardiovascular events in patients with diabetic nephropathy.

Yuyun MF, Dinneen SF, Edwards OM, Wood E, Wareham NJ.

Diabet Med. 2003 Apr;20(4):277-82. Erratum in: Diabet Med. 2003 Jun;20(6):512.


Proteinuria and the risk of developing end-stage renal disease.

Iseki K, Ikemiya Y, Iseki C, Takishita S.

Kidney Int. 2003 Apr;63(4):1468-74.


Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.

Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, Coresh J, Levey AS, Sarnak MJ.

J Am Coll Cardiol. 2003 Jan 1;41(1):47-55.


Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate.

Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, Levey AS.

Am J Kidney Dis. 2002 May;39(5):920-9.

Items per page

Supplemental Content

Write to the Help Desk